PD-L1: PD-1 Interaction Contributes to the Functional Suppression of T-Cell Responses to Human Uveal Melanoma Cells In Vitro
Open Access
- 1 June 2008
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 49 (6) , 2518-2525
- https://doi.org/10.1167/iovs.07-1606
Abstract
Purpose. To assess the expression of PD-L1 on human uveal melanomas and its potential to suppress T-cell function. methods. A panel of primary and metastatic uveal melanoma cell lines was evaluated for PD-L1 expression by RT-PCR and flow cytometric analysis. Uveal melanoma-containing eyes were examined for PD-L1 expression by immunohistochemistry. PD-L1 function was tested by coculturing IFN-γ-pretreated uveal melanoma cells with activated Jurkat T cells for 48 hours and assessing T-cell production of IL-2 by ELISA. results. Five of the nine primary and one of the five metastatic uveal melanoma cell lines tested constitutively expressed PD-L1 protein at various levels. However, all primary and metastatic uveal melanoma cell lines upregulated PD-L1 expression after stimulation with IFN-γ. Immunohistochemistry demonstrated that PD-L1 was not expressed by primary uveal melanomas in situ. IL-2 production by activated Jurkat T cells was decreased significantly when the cells were cocultured with IFN-γ-pretreated uveal melanoma cells. More than 70% of IL-2 production was restored by addition of either anti-PD-L1 or anti-PD-1 antibody to the coculture assays (P < 0.01). conclusions. Expression of PD-L1 by uveal melanoma cells regulates T-cell function by suppressing IL-2 production. The results imply that the presence of IFN-γ in the tumor local microenvironment promotes upregulation of PD-L1 expression by uveal melanoma, which may, in part, promote immune escape by impairing T-cell function. The selective blockade of PD-L1 is a potential strategy in T-cell-based immunotherapy for uveal melanoma.Keywords
This publication has 53 references indexed in Scilit:
- Metastatic Uveal Melanoma TherapyInternational Ophthalmology Clinics, 2006
- PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesionEuropean Journal of Immunology, 2005
- PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesisClinical Immunology, 2005
- Epigenetic Silencing of theCIITAGene and Posttranscriptional Regulation of Class II MHC Genes in Ocular Melanoma CellsInvestigative Opthalmology & Visual Science, 2004
- Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesisGastroenterology, 1999
- Melanomas that develop within the eye inhibit lymphocyte proliferationInternational Journal of Cancer, 1997
- The Ocular Melanoma Story LIII Edward Jackson Memorial Lecture: Part IIAmerican Journal of Ophthalmology, 1997
- Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.1996
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996
- Epidemiologic aspects of uveal melanomaSurvey of Ophthalmology, 1988